These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5025456)

  • 1. Use of heparinase to eliminate heparin inhibition in routine coagulation assays.
    Hutt ED; Kingdon HS
    J Lab Clin Med; 1972 Jun; 79(6):1027-34. PubMed ID: 5025456
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methodological aspects of the photometric determination of prothrombin time using chromogenic substrates].
    Dati F; Kolde HJ; Heimburger N; Keller F
    J Clin Chem Clin Biochem; 1986 Nov; 24(11):877-88. PubMed ID: 3806016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On further changes in the coagulation potential during interruption of pregnancy].
    Slunský R; Adamcová M
    Z Geburtshilfe Gynakol; 1965 Oct; 164(2):163-83. PubMed ID: 5887160
    [No Abstract]   [Full Text] [Related]  

  • 4. [Degradation of heparin by bacterial heparinase].
    Yamaha T; Takahashi T; Kimura T
    Eisei Shikenjo Hokoku; 1968; 86():36-40. PubMed ID: 5753681
    [No Abstract]   [Full Text] [Related]  

  • 5. The enzymatic degradation of heparin and heparitin sulfate. 3. Purification of a heparitinase and a heparinase from flavobacteria.
    Hovingh P; Linker A
    J Biol Chem; 1970 Nov; 245(22):6170-5. PubMed ID: 5484472
    [No Abstract]   [Full Text] [Related]  

  • 6. [Single-stage prothrombin time: standardization of reagents; Brazilian thromboplastin reference].
    Guerra CC; Borges DR; Nahas L; Rosenfeld LG
    Rev Paul Med; 1977; 89(1-2):21-3. PubMed ID: 918483
    [No Abstract]   [Full Text] [Related]  

  • 7. The enzymatic degradation of heparin and heparitin sulfate. I. The fractionation of a crude heparinase from flavobacteria.
    Linker A; Hovingh P
    J Biol Chem; 1965 Oct; 240(10):3724-8. PubMed ID: 4221059
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin degradation by a novel microbial heparinase.
    Böhmer LH; Pitout MJ; Allcock JL; Visser L
    Thromb Res; 1990 Nov; 60(4):331-5. PubMed ID: 2087692
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
    Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
    Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of the activated partial thromboplastin time for determination of plasma heparin concentration and half-life in human subjects.
    Baele G; De Broe M; De Weerdt GA; Ringoir S; Barbier F
    Thromb Diath Haemorrh; 1972 Feb; 27(1):107-13. PubMed ID: 5033660
    [No Abstract]   [Full Text] [Related]  

  • 11. [Present state of heparin therapy].
    Blatrix C; Soulier JP; Vacheron A; Cornu P
    Presse Med (1893); 1969 Mar; 77(15):553-6. PubMed ID: 5796027
    [No Abstract]   [Full Text] [Related]  

  • 12. Thromboplastin as a clotting factor.
    Quick AJ
    Thromb Diath Haemorrh; 1971 Jun; 25(2):381-7. PubMed ID: 5568054
    [No Abstract]   [Full Text] [Related]  

  • 13. Coagulation assays.
    Bates SM; Weitz JI
    Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
    [No Abstract]   [Full Text] [Related]  

  • 14. [Simple search test in pre- and postoperative blood coagulation disorders].
    Encke A
    Z Prakt Anasth; 1970 Feb; 5(1):66-8. PubMed ID: 4256219
    [No Abstract]   [Full Text] [Related]  

  • 15. [Definition of the therapeutic scope of oral anti-coagulation. Evaluation of a new test system (Hepato-Quick)].
    Beck EA; Muschietti F
    Schweiz Med Wochenschr; 1974 Aug; 104(35):1218-21. PubMed ID: 4445847
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating heparin during liver transplantation.
    Chapin JW; Peters KR; Winslow J; Becker GL; Skinner H
    Transplant Proc; 1993 Apr; 25(2):1803. PubMed ID: 8470172
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation and performance characteristics of the automated coagulation analyzer ACL TOP.
    Appert-Flory A; Fischer F; Jambou D; Toulon P
    Thromb Res; 2007; 120(5):733-43. PubMed ID: 17275069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
    Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
    Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the quality of prothrombin time technique in the Basque Country].
    Vacas M; Lafuente PJ; Aguirrebeitia MJ; Iriarte JA
    Sangre (Barc); 1998 Feb; 43(1):41-5. PubMed ID: 9577180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of phospholipid reagents used in coagulation II: factors influencing their sensitivity to heparin.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):634-7. PubMed ID: 7314057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.